| Authors: |
Wenham RM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA. Electronic address: robert.wenham@moffitt.org., Buras AL; Salem Health, Gynecologic Oncology, Salem, OR, USA., Gordon SW; Sidney Kimmel Comprehensive Cancer Center, Division of Hematology and Oncology, Thomas Jefferson University, Philadelphia, PA, USA; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA., Whiting J; Moffitt Cancer Center, Department of Biostatistics & Bioinformatics, Tampa, FL, USA., Fridley BL; Children's Mercy Kansas City, Division of Health Services and Outcomes Research, Kansas City, MO, USA., Dorman D; Clinical Trials Office, Moffitt Cancer Center, Tampa, FL, USA., Apte SM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Chon HS; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Shahzad MM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Randall LM; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA; Inova Health System, Gynecologic Oncology Women's Service Line, Fairfax, VA, USA., Havrilesky LJ; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute., Davidson BA; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute., Secord AA; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute. |
